Gene Therapy Panel (Alliance for Regenerative Medicine)
Andy Holt, RhiaPharmaceutical’s VP of Business Development, joined the panel discussion on gene therapy hosted by the Alliance for Regenerative Medicine in April 2019.
Andy Holt, RhiaPharmaceutical’s VP of Business Development, joined the panel discussion on gene therapy hosted by the Alliance for Regenerative Medicine in April 2019.